REQUEST A DEMO
Total
USD $0.00
Search more companies

Jiangsu Nhwa Pharmaceutical Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jiangsu Nhwa Pharmaceutical Co.,Ltd Profile Updated: April 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Jiangsu NHWA Pharmaceutical Co., Ltd. not only has over 10 automatic production lines including tablets, capsules,water injections, powder injections, granules etc. but alsohas 22 kinds raw materials and over 90 types west medicine preparations, with an immerse production capability of solid preparation 1 billion tablets a year and injection 10million a year. The company is focus on central nervousdrugs, both raw materials and final products mainly inanesthesia, spirit and nerve drugs and the products aremostly used in the fields of the treatment of anesthesiasedation, analgesics, anti-psychosis,anti-anxiety/depression, anti-epilepsy and other diseases.

Headquarters
Nhwa Science and Technology Building, No. 31, Longhu West Road, Economic and Technological Development Zone, Xuzhou City, Jiangsu Province
Xuzhou; Jiangsu; Postal Code: 221001

Contact Details: Purchase the Jiangsu Nhwa Pharmaceutical Co.,Ltd report to view the information.

Website: http://www.nhwa-group.com

Basic Information
Total Employees:
Purchase the Jiangsu Nhwa Pharmaceutical Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Jiangsu Nhwa Pharmaceutical Co.,Ltd report to view the information.
Registered Capital:
Purchase the Jiangsu Nhwa Pharmaceutical Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Jiangsu Nhwa Pharmaceutical Co.,Ltd report to view the information.
Incorporation Date:
March 29, 1999
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
31.77%
Purchase this report to view the information.
4.91%
Purchase this report to view the information.
3.96%
Purchase this report to view the information.
3.96%
Purchase this report to view the information.
3.72%
Subsidiaries
Hong Kong Enhua Pharmaceutical Co., Ltd.
100%
Jiangsu Enhua Hexin Pharmaceutical Marketing Co., Ltd.
100%
Shanghai Shujing Biotechnology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Jiangsu Nhwa Pharmaceutical Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
15.16%
Total operating revenue
14.59%
Operating profit (EBIT)
16.55%
EBITDA
15.94%
Net Profit (Loss) for the Period
17.53%
Total assets
11.57%
Total equity
14.89%
Operating Profit Margin (ROS)
0.27%
Net Profit Margin
0.39%
Return on Equity (ROE)
0.08%
Debt to Equity Ratio
0.2%
Quick Ratio
1.3%
Cash Ratio
0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?